A Randomized, Double-Blind, Placebo-Controlled, Gene-Delivery Clinical Trial of rAAVrh74.MHCK7.micro-dystrophin for Duchenne Muscular Dystrophy

被引：0
|
作者：
Mendell, Jerry R. [1 ,2 ]
Shieh, Perry B. [3 ]
Sahenk, Zarife [1 ]
Lehman, Kelly [1 ]
Lowes, Linda P. [1 ]
Reash, Natalie F. [1 ]
Iammarino, Megan [1 ]
Alfano, Lindsay N. [1 ]
Woods, Jeremy D. [3 ]
Skura, Christy L. [3 ]
Mao, Howard C. [3 ]
Staudt, Loretta A. [3 ]
Potter, Rachael A. [1 ,4 ]
Griffin, Danielle [1 ,4 ]
Lewis, Sarah [1 ,4 ]
Hu, Larry [4 ]
Upadhyay, Sameer [4 ]
Singh, Teji [4 ]
Rodino-Klapac, Louise R. [4 ]
机构：
[1] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA
[2] Ohio State Univ, Dept Pediat & Neurol, Columbus, OH 43210 USA
[3] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA
[4] Sarepta Therapeut Inc, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
231
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [41] Design of a confirmatory phase 3, multicenter, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
    Barth, J.
    Reha, A.
    Spiegel, R.
    Elfring, G. L.
    Husain, M.
    Peltz, S. W.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 804 - 804
  • [42] Design of a confirmatory phase 3, multicentre, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
    Barth, J.
    Reha, A.
    Spiegel, R.
    Elfring, G. L.
    Husain, M.
    Peltz, S. W.
    JOURNAL OF NEUROLOGY, 2014, 261 : S140 - S140
  • [43] Design of a confirmatory phase 3, multicentre, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
    Barth, J.
    Reha, A.
    Spiegel, R.
    Elfring, G. L.
    Husain, M.
    Peltz, S. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 201 - 201
  • [44] Tamoxifen in Duchenne muscular dystrophy: A multicentre, randomised, double-blind, placebo-controlled, phase 3 safety and efficacy 48-week trial
    Henzi, B.
    Schmidt, S.
    Nagy, S.
    Rubino-Nacht, D.
    Schaedelin, S.
    Putananickal, N.
    Hafner, P.
    Dorchies, O.
    Fischer, D.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [45] Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    McDonald, Craig M.
    Campbell, Craig
    Erazo Torricelli, Ricardo
    Finkel, Richard S.
    Flanigan, Kevin M.
    Goemans, Nathalie
    Heydemann, Peter
    Kaminska, Anna
    Kirschner, Janbernd
    Muntoni, Francesco
    Nascimento Osorio, Andres
    Schara, Ulrike
    Sejersen, Thomas
    Shieh, Perry B.
    Sweeney, H. Lee
    Topaloglu, Haluk
    Tulinius, Mar
    Vilchez, Juan J.
    Voit, Thomas
    Wong, Brenda
    Elfring, Gary
    Kroger, Hans
    Luo, Xiaohui
    McIntosh, Joseph
    Ong, Tuyen
    Riebling, Peter
    Souza, Marcio
    Spiegel, Robert J.
    Peltz, Stuart W.
    Mercuri, Eugenio
    LANCET, 2017, 390 (10101): : 1489 - 1498
  • [46] Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double-blind, placebo-controlled, dose-titration trial
    Wagner, Kathryn R.
    Kuntz, Nancy L.
    Koenig, Erica
    East, Lilly
    Upadhyay, Sameer
    Han, Baoguang
    Shieh, Perry B.
    MUSCLE & NERVE, 2021, 64 (03) : 285 - 292
  • [47] The clinical effect of benesco™ on reflux symptoms: A double-blind randomized placebo-controlled trial
    Kuipers, Thijs
    Oude Nijhuis, Renske A. B.
    Schuitenmaker, Jeroen M.
    Bredenoord, Albert J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (10):
  • [48] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
    Campillo, Jeremy T.
    Bikita, Paul
    Hemilembolo, Marlhand
    Louya, Frederic
    Missamou, Francois
    Pion, Sebastien D. S.
    Boussinesq, Michel
    Chesnais, CedricB
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27
  • [49] A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis
    Nassiri-Kashani, M
    Firooz, A
    Khamesipour, A
    Moitahed, F
    Nilforoushzadeh, M
    Hejazi, H
    Bouzari, N
    Dowlati, Y
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (01) : 80 - 83
  • [50] HSDD, Flibanserin, and Eye Dynamics: A Double-Blind Randomized Placebo-Controlled Clinical Trial
    Cacioppo, Stephanie
    Kaske, Erika
    Siewsrichol, Wasuwat
    Millheiser, Leah
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 101S - 101S
12345